Log in to save to my catalogue

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged...

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_152

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023

About this item

Full title

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023

Publisher

US: Oxford University Press

Journal title

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
The bivalent mRNA COVID-19 vaccine booster dose, composed of mRNA from ancestral and Omicron BA.4/BA.5 strains, was recommended for adolescents aged ≥12 years on September 1, 2022, and for children aged 5–11 years on October 12, 2022. However, data demonstrating the effectiveness of bivalent boosters among children and ado...

Alternative Titles

Full title

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1093_ofid_ofad500_152

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_152

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofad500.152

How to access this item